RevMab

anti-CD79a (C-term) (human), Rabbit Monoclonal (RM297)

CHF 459.00
In stock
REV-31-1182-00-R100100 µlCHF 459.00
More Information
Product Details
Synonyms B-cell Antigen Receptor Complex-associated Protein alpha Chain; Membrane-bound Immunoglobulin-associated Protein
Product Type Recombinant Antibody
Properties
Clone RM297
Isotype Rabbit IgG
Source/Host Rabbit
Immunogen/Antigen A peptide corresponding to the C-terminus of human CD79a.
Application

Immunohistochemistry (IHC): 1:100-1:200 dilution
Western Blot (WB): 1:100-1:200 dilution

Crossreactivity Human
Specificity

This antibody reacts to human CD79a.

Purity Protein A purified.
Purity Detail Protein A affinity purified from an animal origin-free culture supernatant.
Concentration N/A
Formulation Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide.
Isotype Negative Control

Rabbit IgG

Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Accession Number P11912
Declaration Manufactured by RevMab Biosciences.
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

CD79a is a disulphide-linked heterodimer together with CD79b. CD79a plays multiple and diverse roles in B cell development and function. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells. Association of the CD79a/b heterodimer with the immunoglobulin heavy chain is required for surface expression of the BCR and BCR induced calcium flux and protein tyrosine phosphorylation. The CD79a protein is present on the surface of B-cells throughout their life cycle, and is absent on all other healthy cells, making it a highly reliable marker for B-cells in immunohistochemistry. The protein remains present when B cells transform into active plasma cells, and is also present in virtually all B-cell neoplasms, including B-cell lymphomas, plasmacytomas and myelomas. It is also present in abnormal lymphocytes associated with some cases of Hodgkins disease. Because even on B cell precursors, it can be used to stain a wider range of cells compared to the alternative B cell marker CD20 and is often used together in immunohistochemistry panels.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.